The role of mitochondrial dysfunction in periodontitis: From mechanisms to therapeutic strategy
Journal of Periodontal Research · 2023-10 · 58 (5) · 853-863
DOI: 10.1111/jre.13152 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Periodontal Research, online erschienen am 18.06.2023. Verfasst von Wentao Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Oxidative Stress, Periodontitis. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China/Outstanding Youth Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Periodontitis is an inflammatory and destructive disease of tooth‐supporting tissue and has become the leading cause of adult tooth loss. The most central pathological features of periodontitis are tissue damage and inflammatory reaction. As the energy metabolism center of eukaryotic cells, mitochondrion plays a notable role in various processes, such as cell function and inflammatory response. When the intracellular homeostasis of mitochondrion is disrupted, it can lead to mitochondrial dysfunction and inability to generate adequate energy to maintain basic cellular biochemical reactions. Recent studies have revealed that mitochondrial dysfunction is closely related to the initiation and development of periodontitis. The excessive production of mitochondrial reactive oxygen species, imbalance of mitochondrial biogenesis and dynamics, mitophagy and mitochondrial DNA damage can all affect the development and progression of periodontitis. Thus, targeted mitochondrial therapy is potentially promising in periodontitis treatment. In this review, we summarize the above mitochondrial mechanism in the pathogenesis of periodontitis and discuss some potential approaches that can exert therapeutic effects on periodontitis by modulating mitochondrial activity. The understanding and summary of mitochondrial dysfunction in periodontitis might provide new research directions for pathological intervention or treatment of periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Stomatology, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
- Department of Endodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Xiangya Stomatological Hospital and Xiangya School of Stomatology, Central South University, Changsha, China.
- The First Clinical Medical College, Wenzhou Medical University, Wenzhou, China.
- Department of Periodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
- Department of Prosthodontics, School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Shengbin Huang
Förderung
- Zhejiang Provincial Natural Science Foundation of China/Outstanding Youth Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Jiang, W., Wang, Y., Cao, Z., Chen, Y., Si, C., Sun, X., & Huang, S. (2023). The role of mitochondrial dysfunction in periodontitis: From mechanisms to therapeutic strategy. Journal of Periodontal Research, 58(5), 853-863. https://doi.org/10.1111/jre.13152
Vancouver
Jiang W, Wang Y, Cao Z, Chen Y, Si C, Sun X, et al. The role of mitochondrial dysfunction in periodontitis: From mechanisms to therapeutic strategy. Journal of Periodontal Research. 2023;58(5):853-863. doi:10.1111/jre.13152
BibTeX
@article{Jiang2023,
author = {Jiang, Wentao and Wang, Yujing and Cao, Zelin and Chen, Yifan and Si, Chenli and Sun, Xiaoyu and Huang, Shengbin},
title = {The role of mitochondrial dysfunction in periodontitis: From mechanisms to therapeutic strategy},
journal = {Journal of Periodontal Research},
year = {2023},
volume = {58},
number = {5},
pages = {853--863},
doi = {10.1111/jre.13152}
}
EUVIMED